Literature DB >> 20538656

Nonsense mutation in MERTK causes autosomal recessive retinitis pigmentosa in a consanguineous Pakistani family.

Amber Shahzadi1, S Amer Riazuddin, Shahbaz Ali, David Li, Shaheen N Khan, Tayyab Husnain, Javed Akram, Paul A Sieving, J Fielding Hejtmancik, Sheikh Riazuddin.   

Abstract

BACKGROUND: Retinitis pigmentosa (RP) is one of the most common ophthalmic disorders affecting one in approximately 5000 people worldwide. A nuclear family was recruited from the Punjab province of Pakistan to study the genetic basis of autosomal recessive RP.
METHODS: All affected individuals underwent a thorough ophthalmic examination and the disease was characterised based upon results for fundus photographs and electroretinogram recordings. Genomic DNA was extracted from peripheral leucocytes. Exclusion studies were performed with short tandem repeat (STR) markers flanking reported autosomal recessive RP loci. Haplotypes were constructed and results were statistically evaluated.
RESULTS: The results of exclusion analyses suggested that family PKRP173 was linked to chromosome 2q harbouring mer tyrosine kinase protooncogene (MERTK), a gene previously associated with autosomal recessive RP. Additional STR markers refined the critical interval and placed it in a 13.4 cM (17 Mb) region flanked by D2S293 proximally and D2S347 distally. Significant logarithm of odds (LOD) scores of 3.2, 3.25 and 3.18 at theta=0 were obtained with markers D2S1896, D2S2269 and D2S160. Sequencing of the coding exons of MERTK identified a mutation, c.718G-->T in exon 4, which results in a premature termination of p.E240X that segregates with the disease phenotype in the family.
CONCLUSION: Our results strongly suggest that the nonsense mutation in MERTK, leading to premature termination of the protein, is responsible for RP phenotype in the affected individuals of the Pakistani family.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538656      PMCID: PMC3393880          DOI: 10.1136/bjo.2009.171892

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  13 in total

Review 1.  Retinitis pigmentosa.

Authors:  Dyonne T Hartong; Eliot L Berson; Thaddeus P Dryja
Journal:  Lancet       Date:  2006-11-18       Impact factor: 79.321

2.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

3.  Molecular diagnostics for retinitis pigmentosa.

Authors:  K Y Yeung; L Baum; W M Chan; D S Lam; A K Kwok; C P Pang
Journal:  Clin Chim Acta       Date:  2001-11       Impact factor: 3.786

4.  Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa.

Authors:  A Gal; Y Li; D A Thompson; J Weir; U Orth; S G Jacobson; E Apfelstedt-Sylla; D Vollrath
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

5.  Clinical characterisation of a family with retinal dystrophy caused by mutation in the Mertk gene.

Authors:  M Tschernutter; S A Jenkins; N H Waseem; Z Saihan; G E Holder; A C Bird; S S Bhattacharya; R R Ali; A R Webster
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

6.  Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat.

Authors:  P M D'Cruz; D Yasumura; J Weir; M T Matthes; H Abderrahim; M M LaVail; D Vollrath
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

7.  MERTK arginine-844-cysteine in a patient with severe rod-cone dystrophy: loss of mutant protein function in transfected cells.

Authors:  Christina L McHenry; Yuhui Liu; Wei Feng; Anita R Nair; Kecia L Feathers; Xiaoling Ding; Andreas Gal; Douglas Vollrath; Paul A Sieving; Debra A Thompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-05       Impact factor: 4.799

Review 8.  Retinitis pigmentosa: genes, proteins and prospects.

Authors:  M M Hims; S P Diager; C F Inglehearn
Journal:  Dev Ophthalmol       Date:  2003

Review 9.  Retinal photoreceptor dystrophies LI. Edward Jackson Memorial Lecture.

Authors:  A C Bird
Journal:  Am J Ophthalmol       Date:  1995-05       Impact factor: 5.258

10.  A new locus for autosomal recessive congenital cataract identified in a Pakistani family.

Authors:  Haiba Kaul; S Amer Riazuddin; Afshan Yasmeen; Sadia Mohsin; Mohsin Khan; Idrees A Nasir; Shaheen N Khan; Tayyab Husnain; Javed Akram; J Fielding Hejtmancik; Sheikh Riazuddin
Journal:  Mol Vis       Date:  2010-02-16       Impact factor: 2.367

View more
  16 in total

1.  Tyrosine-mutant AAV8 delivery of human MERTK provides long-term retinal preservation in RCS rats.

Authors:  Wen-Tao Deng; Astra Dinculescu; Qiuhong Li; Sanford L Boye; Jie Li; Marina S Gorbatyuk; Jijing Pang; Vince A Chiodo; Michael T Matthes; Douglas Yasumura; Li Liu; Fowzan S Alkuraya; Kang Zhang; Douglas Vollrath; Matthew M LaVail; William W Hauswirth
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-06       Impact factor: 4.799

2.  Gene Therapy for MERTK-Associated Retinal Degenerations.

Authors:  Matthew M LaVail; Douglas Yasumura; Michael T Matthes; Haidong Yang; William W Hauswirth; Wen-Tao Deng; Douglas Vollrath
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 3.  TAM receptor signaling and autoimmune disease.

Authors:  Carla V Rothlin; Greg Lemke
Journal:  Curr Opin Immunol       Date:  2010-10-26       Impact factor: 7.486

Review 4.  A comprehensive review of retinal gene therapy.

Authors:  Shannon E Boye; Sanford L Boye; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2013-01-29       Impact factor: 11.454

5.  Mutations in RLBP1 associated with fundus albipunctatus in consanguineous Pakistani families.

Authors:  Shagufta Naz; Shahbaz Ali; S Amer Riazuddin; Tahir Farooq; Nadeem H Butt; Ahmad U Zafar; Shaheen N Khan; Tayyab Husnain; Ian M Macdonald; Paul A Sieving; J Fielding Hejtmancik; Sheikh Riazuddin
Journal:  Br J Ophthalmol       Date:  2011-03-28       Impact factor: 4.638

6.  Preclinical potency and safety studies of an AAV2-mediated gene therapy vector for the treatment of MERTK associated retinitis pigmentosa.

Authors:  Thomas J Conlon; Wen-Tao Deng; Kirsten Erger; Travis Cossette; Ji-jing Pang; Renee Ryals; Nathalie Clément; Brian Cleaver; Issam McDoom; Shannon E Boye; Marc C Peden; Mark B Sherwood; Corinne R Abernathy; Fowzan S Alkuraya; Sanford L Boye; William W Hauswirth
Journal:  Hum Gene Ther Clin Dev       Date:  2013-04-03       Impact factor: 5.032

7.  A novel MERTK deletion is a common founder mutation in the Faroe Islands and is responsible for a high proportion of retinitis pigmentosa cases.

Authors:  Elsebet Ostergaard; Morten Duno; Mustafa Batbayli; Kaj Vilhelmsen; Thomas Rosenberg
Journal:  Mol Vis       Date:  2011-06-04       Impact factor: 2.367

8.  Detection and validation of novel mutations in MERTK in a simplex case of retinal degeneration using WGS and hiPSC-RPEs model.

Authors:  Pooja Biswas; Shyamanga Borooah; Hiroko Matsui; Marina Voronchikhina; Jason Zhou; Qais Zawaydeh; Pongali B Raghavendra; Henry Ferreyra; S Amer Riazuddin; Karl Wahlin; Kelly A Frazer; Radha Ayyagari
Journal:  Hum Mutat       Date:  2020-12-13       Impact factor: 4.700

9.  Increased expression of MERTK is associated with a unique form of canine retinopathy.

Authors:  Saija J Ahonen; Meharji Arumilli; Eija Seppälä; Osmo Hakosalo; Maria K Kaukonen; András M Komáromy; Hannes Lohi
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

10.  The molecular basis of retinal dystrophies in pakistan.

Authors:  Muhammad Imran Khan; Maleeha Azam; Muhammad Ajmal; Rob W J Collin; Anneke I den Hollander; Frans P M Cremers; Raheel Qamar
Journal:  Genes (Basel)       Date:  2014-03-11       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.